AMA CPT® Assistant - 2022 Issue 7 (July)
New COVID-19 Vaccine Codes: July Update (July Special Update 2022)
July Special Update 2022 page 1 New COVID-19 Vaccine Codes: July Update The Current Procedural Terminology (CPT ® ) Editorial Panel (the Panel) has approved three new vaccine administration codes ( 0091A , 0092A , 0093A ) for the Moderna vaccine product to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) in pediatric patients aged 6 through 11 years. These codes are to be reported with previously established Moderna vaccine product code 91309 . The Panel has also approved an additional vaccine administration code ( 0113A ) that is to be reported with the previously established Moderna vaccine...
Subscribe or sign in to view the full article.
Article Overview
This CPT® Assistant Special Edition update explains July 2022 changes to Moderna COVID-19 vaccine product and administration coding. It is relevant to coders, billers, and clinical documentation teams working with immunization reporting, CPT code updates, and Appendix Q references. The article covers newly established administration codes, revised age applicability for existing codes, related CPT editorial updates, and the role of Appendix Q in organizing vaccine coding guidance.
Why This Topic Matters
COVID-19 vaccine coding changed quickly during 2022, and this update helps users recognize which CPT® vaccine products and administration codes were newly added or revised. It also highlights where the code-set guidance was organized and how the changes were reflected in supporting CPT reference materials.
Article Sections
-
July Special Update 2022 page 1
Introduces the July 2022 CPT® vaccine coding update and summarizes the scope of the Moderna-related changes discussed in the article.
-
Immunization Administration for Vaccines/Toxoids
Presents the updated Moderna immunization administration codes and their associated vaccine product references. It also notes age-related applicability and related CPT parenthetical guidance.
-
Vaccines, Toxoids
Lists the Moderna vaccine product codes discussed in the update and the administration codes linked to each product. This section also reflects the age-group revisions covered in the article.
-
Table 1 Excerpt from Appendix Q: Moderna COVID-19 Vaccine Codes*
Shows an excerpt of Appendix Q organizing Moderna vaccine product codes, associated administration codes, and patient age categories. The table highlights the coding changes addressed in the article.
-
Clinical Example (0091A) / Description of Procedure (0091A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
-
Clinical Example (0092A) / Description of Procedure (0092A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
-
Clinical Example (0093A) / Description of Procedure (0093A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
-
Clinical Example (0113A) / Description of Procedure (0113A)
Provides a clinical scenario and procedural context for one of the newly discussed Moderna pediatric administration codes.
What You Will Learn
- How the July 2022 CPT® update organized Moderna COVID-19 vaccine coding changes
- Which areas of the CPT code set were revised for pediatric and adult vaccine reporting
- How Appendix Q is used to summarize vaccine product and administration code relationships
- What categories of guidance are included in the special edition update
Who Should Read This
- Medical coders
- Billing staff
- Compliance teams
- Clinical documentation specialists
- Practice managers
- Immunization reporting staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
